Abhishek Srivastava
Geen lopende functies
Vermogen: 145 $ op 31-03-2024
Profiel
Abhishek Srivastava is currently working as Vice President-Technical Operations at Alaunos Therapeutics, Inc. He previously worked as Vice President-Cell Therapy Development at Athenex, Inc. He holds a doctorate degree from the University of Louisville School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-03-2023 | 80 ( 0.00% ) | 145 $ | 31-03-2024 |
Eerdere bekende functies van Abhishek Srivastava
| Bedrijven | Functie | Einde |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-10-2023 |
| ATHENEXPAR | Corporate Officer/Principal | - |
Opleiding van Abhishek Srivastava
| University of Louisville School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Athenex, Inc.
 Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
